ConMed
- Market cap
- 1.32B
- P/E (TTM)i
- 23.91
- P/Bi
- 1.27
- EPSi
- 1.51
- Div yieldi
- 0.45%
- 52W posi
- 58%
Anonymous reader poll. Unscientific, not investment advice.
About ConMed
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
- Founded
- 1970
- CEO
- Mr. Patrick J. Beyer
- Employees
- 3,900
- Headquarters
- Largo, Florida, United States of America
- Fiscal year end
- 12-31
- Website
- conmed.com
Company profile
- Exchange
- US
- Symbol
- CNMD
- Market-cap rank
- #3018
- Listing date
- 1970-01-01
- Market cap
- 1.32B
- Float cap
- 1.31B
- Shares out
- 29.95M
- Float shares
- 29.66M
Sectors & themes
Quote time 2026-10-08 02:22:19 · For reference only, not investment advice and not tailored to your situation.